PureCircle Gets FDA GRAS “No Objection” for New Rebaudioside D

PureCircle said the United States Food and Drug Administration (FDA) has issued a No Objection letter for the use of PureCircle’s Rebaudioside D (Reb D) as a general purpose sweetener for foods and beverages in the U.S.

PureCircle, which said the product's commercialization will play an important role in extending the company’s breakthrough Stevia 3.0 innovation, claims its research has indicated that high purity Reb D has one of the best sweetness profiles of any steviol glycoside from the stevia leaf.

"The clean sweetness of PureCircle’s high purity Reb D has garnered broad commercial interest from customers seeking to develop naturally sweetened formulations with very low to no calories, particularly in food and beverages with higher sweetness levels, such as carbonated soft drinks," the company said. 

With GRAS affirmation, PureCircle is prepared for immediate commercialization of Reb D.

“We have invested over $300 million in a supply chain infrastructure capable of delivering breakthrough ingredient innovation. We are proud to now work with our customers to turn this investment into breakthrough food and beverage solutions," said Jason Hecker, vice president of global marketing & innovation, PureCircle. 

More in Regulatory & Research